A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle Osseuse.
Cavazzana-Calvo M, Bordigoni P, Michel G, Esperou H, Souillet G, Leblanc T, Stephan JL, Vannier JP, Mechinaud F, Reiffers J, Vilmer E, Landman-Parker J, Benkerrou M, Baruchel A, Pico J, Bernaudin F, Bergeron C, Plouvier E, Thomas C, Wijdenes J, Lacour B, Blanche S, Fischer A.
Cavazzana-Calvo M, et al. Among authors: souillet g.
Br J Haematol. 1996 Apr;93(1):131-8. doi: 10.1046/j.1365-2141.1996.4831024.x.
Br J Haematol. 1996.
PMID: 8611446
Clinical Trial.